Company Overview of Needham & Company, LLC
Needham & Company, LLC is a boutique investment banking firm. The firm’s principal activities involve advisory and transaction-related services, with a specific focus on public and private financings, mergers, acquisitions and divestitures, equity research and institutional sales and trading. Its strategic advisory services cover mergers and acquisitions, divestitures and exclusive sales, fairness opinions, joint ventures, restructuring, leveraged buyouts and privatizations, spin-off and equity carve-out, takeover defense, and valuation advisory services. Additionally, it provides growth capital, acquisition financing, recapitalization, shareholder liquidity, and corporate and venture servic...
445 Park Avenue
New York, NY 10022
Founded in 1985
Key Executives for Needham & Company, LLC
Chief Executive Officer and President
Managing Director and Co-Founder
Managing Director and Chief Financial Officer
Compensation as of Fiscal Year 2016.
Needham & Company, LLC Key Developments
Needham & Company, LLC Announces Executive Appointments
Apr 18 16
Needham & Company, LLC announced the addition of several key sales, trading and capital markets professionals, highlighting the Firm’s commitment to growing a differentiated institutional equities franchise. Greg Giannakopoulos recently joined the Firm as Head of Institutional Sales and is a member of the Firm’s Operating and Commitment Committees. Greg is responsible for leading the delivery of Needham’s research, corporate access, and investment banking services to the Firm’s institutional clients. Greg brings 16 years of capital markets and equity sales production and leadership experience from Raymond James and Deutsche Bank. Eric Ritter joins the Firm as a Managing Director in Institutional Sales and will be responsible for growing the Firm’s institutional relationships with hedge funds domestically with a focus on New York and Connecticut. Eric brings 15 years of capital markets and institutional sales experience to the Firm and joins from Deutsche Bank, where he was most recently responsible for leading the firm’s middle markets sales effort domestically. Frank Hourigan joins the Firm as a Principal in Institutional Sales, and will be responsible for growing the Firm’s institutional client relationships in New York and in various regions domestically. Frank brings 18 years of industry and institutional sales experience to the Firm and joins from Sanford C. Bernstein & Co., where he spent eight years covering buy side institutions across the country. David Newcomb joins the Firm as a Principal and Institutional Healthcare Sector Sales Specialist. David will be responsible for growing the Firm’s institutional client relationships with healthcare and life sciences accounts. David brings 22 years of industry and institutional sales experience to the Firm and joins from Goldman Sachs, where he covered buy side institutions. Prior to Goldman Sachs, David spent eight years with Deutsche Bank as the firm’s Healthcare Sector Sales Specialist. Eric Ritter, Frank Hourigan and David Newcomb will be based in New York and will report to Greg Giannakopoulos, Head of Institutional Sales. Joseph Radic recently joined the Firm as a Managing Director in Trading. Joe brings over 20 years of trading experience to the Firm, including the last 13 years at Sanford C. Bernstein & Co., where he most recently led the firm’s small cap trading effort. Albert Aguiar recently joined the firm as a Managing Director in Sales Trading and will be the Small Cap Specialist. Albert brings 20 years of industry experience to the Firm and joins from Sanford C. Bernstein & Co. Prior to Sanford Bernstein, Albert was responsible for developing the Small Cap sales platforms at both Nomura Securities and UBS and helped launch the Small Cap Desk at Merrill Lynch. Carolyn Horn joined the Firm in October 2015 as a Vice President in Healthcare Capital Markets. Carolyn will play a key role in expanding the Firm’s footprint in the Healthcare market, working closely with both the Firm’s corporate clients and with the Firm’s Investment Banking and equities professionals across the Equity Research, Institutional Sales and Trading groups. Previously, Carolyn was a Healthcare Specialist at JMP Securities and spent several years at the Biotechnology Industry Organization in Washington DC, where she led Investor Relations and Business Development.
CCUR Exploring Strategic Alternatives
Mar 1 16
Concurrent Computer Corporation (NasdaqGM:CCUR) announced that CCUR is exploring strategic alternatives to maximize shareholder value. The Board of Directors has created a special committee of directors and CCUR has engaged Needham & Company, LLC to advise it on the process. "Concurrent is well positioned in the industry and continues to win new business in our target markets," said Derek Elder, President and Chief Executive Officer of Concurrent. "This review of strategic alternatives is consistent with our plan to simplify our operating model, sharpen our focus and accelerate our growth plan. We remain committed to providing customers with the best solutions, service and support regardless of the outcome of the process." There is no defined timeline for this strategic review and there can be no assurance that the Company's review of strategic alternatives will result in any transaction.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|